about
Elastin is an essential determinant of arterial morphogenesisEndothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodelingRNA antisense abrogation of MAT1 induces G1 phase arrest and triggers apoptosis in aortic smooth muscle cellsHoming markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging.Molecular advances in cardiac and cardiovascular disease.Life and death of a cardiac myocyte: principles of cellular biology.The cadaveric kidney and the organ shortage--a perspective review.Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damagePotential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries.Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases.Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.Geriatrics: the effect of time in medicine.Molecular biology and gene transfer in atherosclerosis in the stenting era.Induction of endothelial cell activation by a triple helical alpha2beta integrin ligand, derived from type I collagen alpha1(I)496-507.Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function.IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells.Effect of procyanidins from Pinus maritima on glutathione levels in endothelial cells challenged by 3-morpholinosydnonimine or activated macrophages.Procyanidins extracted from pine bark protect alpha-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite.Heparin sensitive and resistant vascular smooth muscle cells: biology and role in restenosis.Genetic analysis of atherosclerosis: a research paradigm for the common chronic diseases.A contemporary research paradigm for the genetic analysis of a common chronic disease.Valve Calcification in Aortic Stenosis: Etiology and Diagnostic Imaging Techniques.Lipoproteins and coagulation.Early oxidative change in low density lipoproteins during progressive chronic renal failure.Pharmacologically activated migration of aortic endothelial cells is mediated through p38 SAPK.Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study.AP-1, but not NF-kappa B, is required for efficient steroid-triggered cell death in Drosophila.Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population.Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro.
P2860
Q24321276-9BE0A08D-D2A2-442C-9723-FCFE6C92B6B7Q27308984-3F516171-6A04-4724-A7EA-9CEC67556CA4Q28582065-BD99EF21-1B6B-434D-9F9F-0081ED994299Q31880062-79C0D4E5-6DAA-4485-BF81-864B26EB9B2FQ33641514-482D35B0-A1F5-410F-8CF9-C84D86E4086DQ34289663-596D3664-E34B-4DF5-A37E-22429002C729Q34459162-C3AC0AE3-A8A9-49FA-8C18-D74F47124275Q36264216-7D23479D-D239-49D2-AB7C-A474B29C43E8Q36482246-01D55C88-B765-458D-A8AE-BE405552633BQ36823662-AE12E413-0619-45E7-88CA-5B28B3B4C0B4Q38165146-2560F47E-CC49-48DD-A4FC-0108047DF173Q38331489-CE095944-A183-4743-A471-59E2228147FDQ40283245-A450F018-A711-41C5-BACD-50F23E77F5D3Q40601689-3DE1AE05-28A6-44E7-9466-AE99DC278115Q40622330-6DE2D304-4310-48E6-AAE9-40F2533A7DC6Q40651409-F953046D-79B8-42F9-B37B-3C3EC8F0CD13Q40711810-4889D8ED-89EC-45B5-B521-8D38B5D1638FQ40902207-5404AD6C-E79B-44E4-AEFA-1C4076A09CA5Q41014257-ADFE413E-3484-43C5-92D0-0662072476C4Q41030320-7F639366-23E4-4B1F-B86C-15D706B0DCBFQ41170278-F166D582-20BC-4EF0-BC8D-5BC34AB0ED37Q41250389-BC7C1C2D-5C63-4F30-B141-CAEAE02CE8F1Q41275411-F44CC39C-A2B6-4B2B-AF3B-BA649596FD01Q41670628-0832E6B4-15D7-4F3F-881A-139EFAFB6AD1Q41769773-CCA7B8E9-EDD1-4ADA-AD9B-947B3B2F58BBQ43263762-6BD06FB6-1A58-4640-806C-332BDF05BFDEQ43687545-F1622229-5D05-430B-88F3-B946469E8696Q47071241-B8DF2687-4DA3-4F20-B867-3A28C3CF8D66Q47112802-7EC320E3-BA13-4FFD-8377-AD4591B06F6EQ51373870-B2D374B4-9931-4E04-893C-D6BE0DC4D0C2
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Molecular therapies for vascular diseases.
@en
type
label
Molecular therapies for vascular diseases.
@en
prefLabel
Molecular therapies for vascular diseases.
@en
P1433
P1476
Molecular therapies for vascular diseases.
@en
P2093
P304
P356
10.1126/SCIENCE.272.5262.689
P407
P577
1996-05-01T00:00:00Z